Optimal time-points for minimal residual disease monitoring change on the basis of the method used in patients with acute myeloid leukemia who underwent allogeneic stem cell transplantation: A comparison between multiparameter flow cytometry and Wilms’ tumor 1 expression

MLA

Rossi, Giovanni, et al. “Optimal Time-Points for Minimal Residual Disease Monitoring Change on the Basis of the Method Used in Patients with Acute Myeloid Leukemia Who Underwent Allogeneic Stem Cell Transplantation: A Comparison between Multiparameter Flow Cytometry and Wilms’ Tumor 1 Expression.” Leukemia Research, vol. 39, no. 2, Feb. 2015, pp. 138–43. EBSCOhost, https://doi.org/10.1016/j.leukres.2014.11.011.

APA

Rossi, G., Carella, A. M., Minervini, M. M., di Nardo, F., Waure, C. de, Greco, M. M., Merla, E., Cillis, G. P. de, Di Renzo, N., Melpignano, A., Capalbo, S., Palumbo, G., Pisapia, G., & Cascavilla, N. (2015). Optimal time-points for minimal residual disease monitoring change on the basis of the method used in patients with acute myeloid leukemia who underwent allogeneic stem cell transplantation: A comparison between multiparameter flow cytometry and Wilms’ tumor 1 expression. Leukemia Research, 39(2), 138–143. https://doi.org/10.1016/j.leukres.2014.11.011

Chicago

Rossi, Giovanni, Angelo Michele Carella, Maria Marta Minervini, Francesco di Nardo, Chiara de Waure, Michele Mario Greco, Emanuela Merla, et al. 2015. “Optimal Time-Points for Minimal Residual Disease Monitoring Change on the Basis of the Method Used in Patients with Acute Myeloid Leukemia Who Underwent Allogeneic Stem Cell Transplantation: A Comparison between Multiparameter Flow Cytometry and Wilms’ Tumor 1 Expression.” Leukemia Research 39 (2): 138–43. doi:10.1016/j.leukres.2014.11.011.